Clinical trial
A Dose Reduction Immunobridging and Safety Study of Two HPV Vaccines in Tanzanian Girls
NCT02834637 is registered in ClinicalTrials.gov with London School of Hygiene and Tropical Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Dose Reduction Immunobridging and Safety Study of Two HPV Vaccines in Tanzanian Girls
- Lead sponsor
- London School of Hygiene and Tropical Medicine
- Phase
- Phase 3
- Overall status
- Active, not recruiting
- Start date
- February 23, 2017
- Completion date
- March 31, 2027
- Enrollment
- 930 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
human papilloma virus